Key facts
- It has raised $40K; the latest was Early Stage VC ($40K) in Aug 2025.
- Notable investors include Invantage Group.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Curotel
- ·The full record, as it builds
Funding rounds
No funding rounds for Curotel are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Curotel
Developer of a medical-grade telemedicine platform and device designed to revolutionize healthcare by providing accessible, affordable and comprehensive remote diagnostics and checkups. The company offers a multi-functional, medical-grade tele-diagnosis device, which integrates essential monitoring tools including a digital stethoscope, otoscope, oximeter, blood pressure monitor and thermometer with real-time data transfer via an app, enabling customers to access comprehensive, objective remote health monitoring and virtual consultations at home, significantly reducing wait times and costs for both patients and healthcare providers.
- Sector
- Healthcare
- HQ
- Morristown, NJ, United States
- Founded
- 2025
- Employees
- 2
- Website
- curotel.com/
- Ownership
- Privately Held (backing)
Curotel doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Curotel shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Curotel in its N-PORT filings yet. We sweep new filings monthly.